Biktarvy | HealthCare Africa Magazine

GSK’s ViiV Healthcare settles patent row with Gilead Sciences

2 February 20222 February 2022

USA – Viiv Healthcare, a specialist HIV company majority-owned by GlaxoSmithKline with Pfizer and Japan’s Shionogi as shareholders, has settled a global patent infringement lawsuit with Gilead Sciences. The case…

Merck’s phase 3 trials of fixed dose HIV-1 therapy achieve primary endpoint

26 October 202126 October 2021

USA – Merck has announced a positive top-line results from two pivotal Phase 3 trials of the investigational, once-daily oral fixed dose combination pill of doravirine/islatravir (DOR/ISL) in adults with…